|
Real-time Estimate
Cboe BZX
12:03:12 10/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 804.16 USD | -0.76% |
|
-5.59% | +4.22% |
| 10:38pm | BMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $920 From $800, Keeps Outperform Rating | MT |
| 02/09 | Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says | MT |
| Market Cap | 80.91B 69.57B 65.45B 59.73B 111B 7,671B 112B 775B 300B 3,921B 304B 297B 12,477B | P/E 2026 * |
18.8x | P/E 2027 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 74.05B 63.66B 59.89B 54.66B 102B 7,020B 103B 710B 275B 3,588B 278B 272B 11,418B | EV / Sales 2026 * |
4.38x | EV / Sales 2027 * | 3.81x |
| Free-Float |
71.06% | Yield 2026 * |
0.48% | Yield 2027 * | 0.55% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Xetra
| RGO | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Boerse Muenchen
| RGO | Real-time | |
|
London S.E.
| 0R2M | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript : Regeneron Pharmaceuticals, Inc.
| 1 day | -0.52% | ||
| 1 week | -5.59% | ||
| Current month | +0.67% | ||
| 1 month | -0.45% | ||
| 3 months | +30.55% | ||
| 6 months | +2.92% | ||
| Current year | +4.22% |
| 1 week | 799.27 |  | 859.34 |
| 1 month | 775.83 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.76% | -5.59% | +44.54% | -3.49% | 80.91B | |
| -0.78% | -1.52% | -18.45% | -36.25% | 60.46B | |
| -0.91% | -7.39% | +470.74% | +32.00% | 56.02B | |
| -1.77% | -5.26% | -9.16% | +29.36% | 49.63B | |
| -0.68% | -6.80% | -1.72% | +149.33% | 45.88B | |
| -0.39% | -5.26% | +46.91% | -18.52% | 31.4B | |
| +0.59% | -2.72% | +46.41% | +94.58% | 25.22B | |
| -2.00% | -3.54% | -2.68% | +156.40% | 22.25B | |
| -1.79% | -1.58% | +61.89% | +101.89% | 16.59B | |
| -3.15% | -7.97% | -24.67% | +719.34% | 14.38B | |
| Average | -1.14% | -2.11% | +61.38% | +122.46% | 40.27B | |
| Weighted average by Cap. | -0.95% | -1.64% | +78.43% | +61.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.92B 14.55B 13.69B 12.49B 23.31B 1,604B 23.43B 162B 62.74B 820B 63.54B 62.15B 2,609B | 18.44B 15.86B 14.92B 13.61B 25.41B 1,748B 25.54B 177B 68.39B 894B 69.26B 67.74B 2,844B |
| Net income | 4.77B 4.1B 3.86B 3.52B 6.58B 453B 6.61B 45.75B 17.7B 231B 17.92B 17.53B 736B | 5.45B 4.68B 4.4B 4.02B 7.5B 516B 7.54B 52.19B 20.19B 264B 20.45B 20B 840B |
| Net Debt | -6.87B -5.91B -5.56B -5.07B -9.46B -651B -9.51B -65.83B -25.47B -333B -25.79B -25.23B -1,059B | -10.55B -9.07B -8.54B -7.79B -14.54B -1,001B -14.61B -101B -39.13B -511B -39.63B -38.77B -1,627B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | USD 805.75 | -0.56% | 35,045 |
| 08/09/26 | USD 810.31 | -2.10% | 556,536 |
| 04/09/26 | USD 827.72 | -1.87% | 561,170 |
| 03/09/26 | USD 843.47 | -1.00% | 496,255 |
| 02/09/26 | USD 852.03 | +3.42% | 749,453 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
